Results for: drugmaker+sanofi

Amgen tops estimates with 51 percent spike in 1Q profit

Ahead of the Bell: Biogen shares keep climbing

BioMarin will continue Pompe disease drug studies

Drugmakers, Interpol ramp up fight against fakes

FDA accepts application for new Sanofi MS drug

Analysis - Fate of $23 billion L'Oreal stake points to future of Nestle

Analysis - Bribery scandal dents Big Pharma sales in China, GSK hardest hit

Drug companies forge partnerships with top schools

Sanofi bets on inhaled insulin with MannKind deal

Sanofi held talks with Abbott, Mylan about mature drugs - document

Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets -...

India invites U.S. to discuss IP, market access issues

Big Pharma stands to profit by cleaning out its medicine chests

Exclusive: Bayer, Novartis, others eye Merck's consumer health unit -...

U.S. clears AstraZeneca over heart drug trial

Eli Lilly copy of $8 billion Sanofi insulin wins EU green light

Europe's drugmakers fight off generics

Sanofi in deal to transfer Toulouse centre to Evotec

How the wheels came off for Sanofi's CEO

Sanofi shares sink as diabetes sales slow, CEO pressured

Exclusive: Express Scripts presses for more drug savings with coverage list

They Know From Data You Buy Viagra and Want to Sell You More

Insync Buys Nestle, Eyes Roche for Global Fund After Shares Sink